Massive FDA Staff Cuts Jeopardize Drug and Device Review Processes, Threatening Critical User Fee Programs on April 11, 2025 Biopharma regulatory issues Budgets delays drug review HHS layoffs layoffs Medical Devices operational PDUFA regulatory RFK Jr. United States Food and Drug Administration user fee +